Executive Summary
The 13 filings dated November 3, 2026 are a mixed bag for the USA M&A & Takeover Activity stream, which is scoped to merger, acquisition and takeover events.
Only a subset is a true merger or acquisition event: the Starlink AI / Spider Digital business combination (US$250M valuation), the Rising Dragon termination, the WhiteFiber $60M industrial property acquisition, the Braemar Scottsdale asset sale at $372M ($1.8M per key, 5.8% cap rate, 15.0x Hotel EBITDA), and the Blue Acquisition / Blockfusion pending combination. The remaining filings are SPAC governance, capital-structure or IPO housekeeping items (Ocean Capital, Concord II, Newbury Street II, SPACCircle IPO and 13D, Titan investor presentation) that are only tangentially related to M&A flow. Deal-level valuation evidence is thin: the Braemar transaction is the only one with quantified multiples, and the Starlink/Spider Digital filing discloses no financials. The clearest period-over-period signal is Ultragenyx's narrowing net loss (from $180M to $118M in Q3, with revenue up 8.1%), though its CRYSVITA Latin America and Türkiye sales fell 7% YoY. Overall, deal-making in the sample skews toward SPAC-driven combinations and asset monetization rather than large strategic takeovers, and several pending combinations carry execution risk.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · Schedule 13D
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from November 02, 2026.
Investment Signals (12)
- Braemar Hotels & Resorts (BHR) (BULLISH)▲
Closed $372M Four Seasons Scottsdale sale at 15.0x trailing Hotel EBITDA and 5.8% cap rate, unlevered return ~15% vs 10% minimum target; self-managed REIT transition on track for mid-November 2026
- ▲
Definitive business combination agreement assigns Spider Digital a US$250M valuation; PubCo expected to list in the US, but no revenue or earnings disclosed to validate the price
- WhiteFiber, Inc. ↓ (BULLISH)▲
Acquired NC-2 and NC-3 for $60M cash, adding 500,000 sq ft and a combined minimum 60 MW (up to ~200 MW within seven years); non-binding LOIs received, adding optionality on contracted capacity
- Ultragenyx Pharmaceutical (RARE) (BULLISH)▲
Q3 2026 net loss narrowed to $118M ($1.16/share) from $180M ($1.81/share) YoY, revenue up 8.1% to $173M; sale of two priority review vouchers for $413M (~$350M net) materially strengthens liquidity
- Ultragenyx Pharmaceutical (RARE) (BEARISH)▲
CRYSVITA Latin America and Türkiye sales fell 7% YoY to $41M from $47M, and 9M 2026 net loss remains $395M despite the narrowing in Q3
- ▲
Mutual termination of the HZJL merger leaves the SPAC with no completed business combination; noteholder principal now payable only on a future deal and auto-cancelled otherwise, reducing near-term cash obligations
- Ocean Capital Acquisition Corp ↓ (BEARISH)▲
Chairman/CEO Kin (Stephen) Sze and director Dr. Pok Yu (Augustine) Chow resigned October 30, 2026; Yiyan Li appointed CEO and interim principal financial officer with no CFO in place, signaling governance and finance-function gaps
- Concord Acquisition Corp II (CNDAU) ↓ (NEUTRAL)▲
CFO Michele Cito resigned effective October 28, 2026; Charles Coop (CPA/CFA, ex-PwC, Atlas Merchant Capital VP of Finance) appointed, a credentialed replacement but an ongoing leadership change
- SPACCircle Acquisition Corp. ↓ (BULLISH)▲
$100M IPO with trust funded at $10.05/unit (above $10.00 IPO price); over-allotment lapsed and 750,000 founder shares forfeited, reducing sponsor dilution
- SPACCircle Sponsor / 13D (BULLISH)▲
Reporting persons hold 34.50% of 15,266,590 shares, have agreed to vote in favor of any business combination and not to redeem shares, signaling strong sponsor alignment
- Acura Pharmaceuticals (ACUR) (BEARISH)▲
Secured note principal grew from $2.32M to $11.44M (~4.9x) with draw frequency and size rising in 2026 (three $200,000 draws June-August), indicating increasing dependence on related-party financing
- Titan Acquisition Corp. (TACH) ↓ (NEUTRAL)▲
Investor presentation furnished for the OpenPayd business combination; PubCo has filed Form F-4, so the deal is progressing toward shareholder vote, though substantive terms sit in an un-provided Exhibit 99.1
Risk Flags (9)
- WhiteFiber/NC-1 Execution Risk↓ [HIGH RISK]▼
Switchgear commissioning issues delayed NC-1 ramp past the August 2026 target, interrupted billing on the first 20 MW hall, and only ~35 MW of the 40 MW contracted IT load is operational
- WhiteFiber/NC-1 Financing Risk↓ [HIGH RISK]▼
NC-1 initial deployment financing is not closed and the company gives no assurance it will be completed, putting the contracted revenue ramp at risk
- Starlink AI / Spider Digital Deal Conditionality↓ [MEDIUM RISK]▼
Closing depends on two shareholder approvals, PubCo Form F-4 effectiveness and NYSE listing approval, and no financial performance was disclosed to support the US$250M valuation
- Rising Dragon Acquisition Corp. Deal Failure↓ [HIGH RISK]▼
Termination of the HZJL merger without a completed combination, plus restructured noteholder claims, leaves the SPAC dependent on a future Subsequent Business Combination; liquidation risk rises if none closes
- Ocean Capital Governance Vacuum [HIGH RISK]▼
Simultaneous departure of the CEO/Chairman and an independent director, a single-person interim CEO/PFO structure, and no CFO appointed points to heightened internal control and oversight risk
- Ultragenyx Pipeline Setbacks [HIGH RISK]▼
UX701 Wilson disease program terminated after missing pivotal-advancement criteria, GTX-102 Angelman studies wound down, ~20% headcount cut and ~$25M Q4 restructuring charges, with 9M 2026 net loss still $395M
- Acura Pharmaceuticals Leverage Creep [MEDIUM RISK]▼
Secured note balance up ~4.9x since origination to $11.44M and accelerating draws signal a funding gap that may precede dilution or restructuring
- SPACCircle Trust/Redemption Exposure [LOW RISK]▼
Over-allotment lapsed and the company has no completed deal; trust at $10.05 per unit is sensitive to redemption dynamics before a business combination is announced
- Blue Acquisition / Blockfusion Funding Dependence↓ [MEDIUM RISK]▼
Sponsor bridge note of up to $50,000 is non-interest bearing but payable on the earlier of closing or liquidation, with an Event of Default one business day after maturity, indicating thin working capital
Opportunities (8)
- Braemar Hotels & Resorts/Self-Management Catalyst↓ (OPPORTUNITY)◆
Mid-November 2026 completion of the transition to a self-managed REIT, funded by Scottsdale proceeds, could remove external advisor fees and lift per-share earnings; 15.0x Hotel EBITDA sale validates asset NAV
- Ultragenyx/Liquidity Re-rating↓ (OPPORTUNITY)◆
$413M priority review voucher sales (~$350M net) plus 2027 cost targets (R&D below $350M, SG&A below $375M) and reaffirmed 2027 GAAP profitability offer a re-rating path if the cost plan is delivered
- WhiteFiber/Capacity Monetization↓ (OPPORTUNITY)◆
Successful NC-1 ramp and closing of NC-1 financing, combined with converting non-binding LOIs on NC-2, NC-3 and NC-1 expansion, could materially expand contracted billing from a land bank of ~200 MW potential
- Starlink AI / Spider Digital Listing Arbitrage↓ (OPPORTUNITY)◆
US listing of PubCo at a US$250M reference valuation may offer re-rating potential versus private-market marks, contingent on F-4 effectiveness and shareholder approvals
- SPACCircle Sponsor Alignment (OPPORTUNITY)◆
34.50% stake with no-redemption commitment and warrants exercisable 30 days post-combination aligns sponsor incentives with completing a deal, supporting a higher probability of consummation
- Titan Acquisition/OpenPayd Combination↓ (OPPORTUNITY)◆
Form F-4 filed and investor presentation issued signal late-stage progress toward a US listing for OpenPayd, a potential catalyst upon shareholder vote
- Rising Dragon Post-Termination Optionality (OPPORTUNITY)◆
With the HZJL deal dissolved and noteholder principal auto-cancelled absent a future combination, the SPAC retains a clean balance sheet for a new target, a potential option value for a sponsor-backed re-deal
- Newbury Street II Extended Runway (OPPORTUNITY)◆
Completion window extended to 27 months from IPO closing, reducing near-term liquidation pressure and giving the sponsor time to source a target
Sector Themes (6)
- SPAC Pipeline Consolidation◆
Of the SPAC filings, Starlink AI/Spider Digital, Titan/OpenPayd and Blue/Blockfusion are advancing toward combinations, while Rising Dragon has terminated; roughly 3 active deals versus 1 failure suggests the pipeline is maturing but selective, with Form F-4 registration a common gating item [SPAC Pipeline Consolidation]
- Sponsor Economics and Dilution Management◆
SPACCircle forfeited 750,000 founder shares and funded trust above IPO price at $10.05 per unit, while Newbury Street II extended its window to 27 months, indicating sponsors are adjusting terms to sustain deal viability in the current market [Sponsor Economics]
- Management and Finance Turnover in SPACs◆
Four of the filings involve CEO, CFO or director changes (Ocean Capital, Concord II), and two SPACs operate with interim or single-person finance leadership, a pattern that raises governance diligence requirements for target shareholders [Management Turnover]
- Asset Monetization over Acquisition in Real Estate and Pharma◆
Braemar sold a 210-room resort at $1.8M per key and Ultragenyx monetized priority review vouchers for $413M, showing that balance-sheet repair through disposals and non-dilutive sales is currently the dominant corporate-transaction theme versus outright buying [Asset Monetization]
- Growth Financing via Secured or Development Capital◆
Acura's secured note has grown ~4.9x and WhiteFiber's NC-1 financing remains open, suggesting capital-intensive data-center and specialty-pharma businesses are leaning on incremental debt facilities whose timing and terms are critical to execution [Financing Dependence]
- Operational Ramp Delays in Infrastructure◆
WhiteFiber's switchgear commissioning delays show that infrastructure acquisitions carry execution risk beyond the purchase price, and buyers should underwrite time-to-revenue assumptions rather than headline capacity figures [Ramp Risk]
Watch List (8)
- Braemar Hotels & Resorts (BHR)👁
Completion of the self-managed REIT transition scheduled for mid-November 2026; watch for the external advisor fee settlement and any updated per-share earnings guidance [mid-November 2026]
-
NC-1 switchgear remediation, full 40 MW billing ramp and closing of the NC-1 deployment financing; any update on converting LOIs for NC-2 and NC-3 into definitive customer agreements [timing not disclosed]
- Ultragenyx Pharmaceutical (RARE)👁
Q4 2026 restructuring charges (~$25M), finalization of the ~20% headcount reduction, and closing of the priority review voucher sales; watch for 2027 R&D and SG&A tracking against the $350M and $375M targets [Q4 2026 / FY2026 results]
-
Shareholder meeting dates, effectiveness of PubCo's Form F-4 and NYSE listing approval, with any disclosed financials for Spider Digital supporting the US$250M valuation [timing not disclosed]
-
Shareholder vote and Form F-4 effectiveness to advance the OpenPayd business combination, including review of the Exhibit 99.1 deal terms [timing not disclosed]
-
Appointment of a permanent CFO and any further board changes following the Sze and Chow resignations; watch for impact on the pending trust and deal timeline [timing not disclosed]
- Acura Pharmaceuticals (ACUR)👁
Next loan draws under the Abuse Deterrent Pharma secured note and any disclosure of a refinancing, equity raise or restructuring to address the ~$11.4M principal balance [ongoing]
-
Any announcement of a Subsequent Business Combination, since noteholder principal is auto-cancelled if none closes, and any liquidation or trust distribution decision [timing not disclosed]
Filing Analyses
(13)
03-11-2026
Starlink AI Acquisition Corporation (NYSE: OTAI), a Cayman Islands blank-check company, and Singapore-based Spider Digital Technology Ltd. announced a definitive business combination agreement dated October 30, 2026, under which both entities would become wholly owned subsidiaries of newly formed PubCo, which is expected to list in the U.S. The deal assigns Spider Digital a valuation of US$250 million for purposes of determining merger consideration. Completion is subject to shareholder approvals from both companies, effectiveness of PubCo's Form F-4 registration statement, and NYSE listing approval; no revenue, earnings, or financial performance metrics were disclosed in the filing.
- · Definitive Agreement dated October 30, 2026; 8-K filed November 03, 2026
- · Structure: Merger Sub I merges into Spider Digital, then Merger Sub II merges into Starlink AI; both survive as wholly owned subsidiaries of PubCo
- · Conditions include shareholder approval by both Starlink AI and Spider Digital, effectiveness of PubCo's Form F-4 registration statement, and NYSE listing approval
- · PubCo intends to file a Form F-4 registration statement including a proxy statement/prospectus for Starlink AI shareholders
- · Starlink AI is a blank check company incorporated as a Cayman Islands exempted company
- · Spider Digital is headquartered in Singapore and operates its own proprietary mining pool system with independent block generation capabilities, without sharing pool control rights or hashrate scheduling authority with third-party operators
- · Forward-looking risks cited include failure to complete the deal by Starlink AI's business combination deadline, minimum net tangible assets requirements following redemptions, digital asset price volatility, and evolving regulatory environment for mining pools
- · Starlink AI's registration statement on Form S-1 is File No. 333-292878
03-11-2026
Rising Dragon Acquisition Corp. (RDACU), a SPAC, and its target HZJL Cayman Limited, together with the Principal Shareholder XB B Limited and Principal Shareholder Representative Bin Xiong, terminated their Agreement and Plan of Merger dated January 27, 2025, effective 11:59 p.m. Eastern Time on October 30, 2026, by mutual written consent. The termination letter also terminates related Additional Agreements and Support Agreements, releases mutual claims, and restructures the unsecured promissory notes issued by the SPAC to SZG Limited and Aurora Beacon LLC so that principal is payable only upon a future Subsequent Business Combination and is automatically cancelled if no such combination closes. The deal's collapse leaves the SPAC without a completed business combination and its noteholders dependent on a future deal.
- · Termination was made under Section 13.1(b) of the Merger Agreement by mutual written consent, with Articles XII (Dispute Resolution) and XIV (Miscellaneous), including the Section 14.14 waiver, surviving termination
- · Company Shareholders Lock-up Agreements and Registration Rights Agreement were never executed or made effective
- · Trust Account waiver under Section 14.14 was reaffirmed; the Company, Principal Shareholder, and Principal Shareholder Representative have no claim to Trust Account funds
- · Subject Promissory Notes survive termination; principal is due only at closing of the first Subsequent Business Combination, and notes are automatically cancelled without payment if the SPAC fails to complete any such combination or if a proposed combination fails to close for reasons not attributable to the SPAC
- · Nondisclosure and non-solicitation or non-compete agreements with Key Personnel remain in effect between their parties
- · Mutual non-disparagement and public-announcement restrictions apply, with exceptions for legally required disclosures and the Form 8-K filing
- · Governing law is New York; disputes are resolved under Article XII of the Merger Agreement
03-11-2026
Ocean Capital Acquisition Corporation, a British Virgin Islands SPAC listed on the NYSE, disclosed that its Chairman, CEO and director Kin (Stephen) Sze resigned effective October 30, 2026, and that independent director Dr. Pok Yu (Augustine) Chow resigned from the Board and all three of its committees on the same date, with both departures stated as not resulting from any disagreement with the Company. On November 2, 2026, the Board appointed Yiyan Li as CEO, Chairman and director (also acting principal financial officer until a CFO is named) and Stephen J. Posner as an independent director and member of the Audit, Governance/Nominating and Compensation Committees. The filing is a leadership transition with no reported transaction, financial results, or merger activity.
- · Ms. Li will also serve as principal financial officer until the Company appoints a Chief Financial Officer, indicating no CFO is currently in place.
- · Dr. Chow resigned from the Audit, Corporate Governance and Nominating, and Compensation Committees, all of which Mr. Posner was appointed to on November 2, 2026.
- · Ms. Li's background includes cross-border e-commerce operations, private investing in pet healthcare (2024-2026), and business consulting (2020-2024).
- · Mr. Posner's background includes investment banking, underwriting and M&A, and a 2025 directorship at Bion Environmental Technologies.
- · Exhibits 10.1 and 10.2 are the CEO/Director Agreement with Ms. Li and the Independent Director Agreement with Mr. Posner, both dated November 2, 2026; their terms were not reproduced in the filing text.
- · The filing is signed by Ms. Li as CEO on November 3, 2026, and lists the company's Units, Ordinary Shares, Rights and Warrants on the NYSE.
- · The 8-K discloses no business combination target, trust account, or merger agreement, so the preliminary Merger/Acquisition classification is not supported by the text.
03-11-2026
Acura Pharmaceuticals disclosed an amended loan schedule to its Secured Promissory Note dated November 10, 2022 with Abuse Deterrent Pharma, LLC, showing the aggregated principal outstanding rising from $2,319,279 at origination to $11,435,886.09 after loan #68 dated October 30, 2026. The filing reflects a continuing pattern of periodic draws, primarily $100,000 tranches, over 2025-2026, with no new equity or operating results disclosed.
- · Aggregated principal rose roughly 4.9x from the original $2.32M note to $11.44M, indicating the secured facility has been drawn substantially beyond its initial amount.
- · Loan draw frequency and size increased in 2026, with three $200,000 draws in June-August 2026 versus $100,000 draws earlier in the year.
- · The schedule was signed by the CFO on October 30, 2026, with the most recent draw on that same date.
03-11-2026
Ultragenyx reported Q3 2026 total revenue of $173 million (vs. $160 million in Q3 2025, +8.1%) and a net loss of $118 million, narrowing from $180 million a year earlier. The company is cutting headcount by roughly 20%, targeting 2027 R&D below $350 million and SG&A below $375 million, and reaffirmed full-year 2027 GAAP profitability. Results were mixed: the company terminated the UX701 Wilson disease program after it missed its pivotal-advancement criteria, wound down GTX-102 Angelman studies, and expects about $25 million of Q4 restructuring charges, while agreements to sell two priority review vouchers for a combined $413 million (about $350 million net) strengthen liquidity.
- · Q3 2026 net loss narrowed to $118M ($1.16/share) from $180M ($1.81/share) in Q3 2025, though 9M 2026 net loss of $395M remains substantial
- · Q3 2026 CRYSVITA Latin America and Türkiye product sales declined 7% YoY to $41M from $47M, partly offsetting growth elsewhere
- · UX701 Wilson disease program terminated after data did not meet criteria for advancing to pivotal Phase 3; the company is working with clinical sites and patient groups on transition
- · GTX-102 Angelman syndrome ongoing studies are being fully wound down
- · UX143 (setrusumab) for osteogenesis imperfecta has an uncertain regulatory path; the company is still engaging regulators on whether a viable path forward exists
- · Company guides 2027 R&D under $350M and SG&A under $375M; net proceeds from PRV sales (~$350M) are a key liquidity source
- · Q4 2026 expected to include ~$25M of severance and restructuring charges, with the reduction in force substantially completed by end of 2026
- · Cash and marketable securities of $401M against Q3 operating cash burn of $43M
- · Reaffirmed 2026 CRYSVITA guidance of $500M–$520M and DOJOLVI guidance of $100M–$110M
03-11-2026
Concord Acquisition Corp II (CNDAU), a Delaware SPAC, disclosed that CFO Michele Cito resigned effective October 28, 2026. The board appointed Charles Coop, Vice President of Finance at Atlas Merchant Capital LLC, to fill the vacancy. The filing reports no financial results, transaction terms, or compensation details.
- · Charles Coop is a CPA and CFA charterholder who joined Atlas Merchant Capital as Controller in June 2021 before becoming VP of Finance.
- · Coop previously was a Manager in Assurance in PricewaterhouseCoopers' Banking and Capital Markets practice.
- · Coop holds a BBA and Master of Accounting from the University of Michigan.
- · The filing does not disclose Coop's compensation arrangements or any related-party relationship with the SPAC's sponsor beyond his Atlas role.
- · The preliminary Merger/Acquisition tag does not appear to be supported by content in this filing, which covers only the officer change.
03-11-2026
Braemar Hotels & Resorts Inc. (NYSE: BHR) closed the sale of the 210-room Four Seasons Resort Scottsdale for $372 million ($1.8 million per key), subject to customary prorations and adjustments. The sale price implies a 5.8% capitalization rate on net operating income (including $23 million of anticipated capital expenditures) and a 15.0x Hotel EBITDA multiple on trailing 12-month results ended September 2026. Management stated the proceeds, together with cash on hand, will fund remaining fees owed to the external advisor under the separation agreement, and that the transition to a self-managed REIT remains on track for mid-November 2026.
- · Hotel EBITDA multiple of 15.0x on trailing 12-month results ended September 2026
- · Management reports an unlevered return of approximately 15%, above its 10% minimum target
- · Property was acquired by Braemar in 2022
- · Sale proceeds plus cash on hand are earmarked to fund remaining external advisor fees under the separation agreement
- · Self-managed REIT transition targeted for mid-November 2026
- · Filing references 2026 Annual Meeting of Stockholders and a proxy solicitation, indicating an active proxy contest context
03-11-2026
Blue Acquisition Corp., a Cayman Islands SPAC (BACCU), issued a promissory note to Dario Dino Ferrari for up to $50,000 to fund working capital needs prior to consummation of its proposed initial business combination with Blockfusion USA, Inc., a Delaware corporation. The note carries no interest, is due on the earlier of the business combination closing or the Company's liquidation, and the Payee has waived any claim against the IPO trust account.
- · Repayment is due on the earlier of consummation of the Blockfusion business combination or the Company's liquidation, and an Event of Default under Section 5(a) triggers after one business day past the Maturity Date.
- · No fees or other amounts are payable to the Payee in connection with any Drawdown Request, and amounts once drawn cannot be redrawn even if prepaid.
- · The Payee irrevocably waives any claim against the Trust Account, which holds IPO proceeds (including deferred underwriting discounts) and private placement proceeds, referencing Form S-1 Registration No. 333-287281.
- · The note is governed by Delaware law and was issued as an unregistered security acquired for investment only under the Securities Act of 1933.
03-11-2026
WhiteFiber completed the previously announced acquisition of two industrial properties in Yadkin County, North Carolina (NC-2 and NC-3) for $60 million in cash, adding about 120 acres and 500,000 sq ft of warehouse space with a combined minimum of 60 MW initial utility capacity (potentially up to about 200 MW within seven years). The company also disclosed NC-1 is behind schedule: switchgear commissioning issues delayed ramp to full contracted billing beyond the August timeframe, with about 35 MW of the contracted 40 MW IT deployment now operational, and the NC-1 financing is still not closed with no assurance it will be completed.
- · NC-1 ramp to full contracted run-rate billing slipped beyond the previously anticipated August 2026 timeframe due to switchgear commissioning issues, which also interrupted service and billing on the first 20 MW data hall
- · NC-1 initial contracted deployment financing with the prospective lending group is not yet closed; parties are still working through documentation and closing requirements, and the company states there is no assurance it will be completed
- · Non-binding letters of intent received for NC-2, NC-3 and NC-1 expansion capacity; company describes advanced discussions but no definitive customer agreements are cited
- · Initial ready-for-service capacity at NC-2 and NC-3 is targeted for late 2027, subject to customary development conditions, with development spending expected to align with definitive customer agreements and financing
- · Seller will continue to occupy portions of the properties under occupancy and partial leaseback arrangements expected to partially offset property carrying costs
- · Total NC-1 development costs are currently expected to remain within the initial budget, and capital investment for the initial contracted deployment is substantially complete
- · Third-quarter 2026 financial results are scheduled for release on November 10, 2026
03-11-2026
Titan Acquisition Corp. (SPAC, Nasdaq: TACHU/TACH/TACHW) furnished under Regulation FD an investor presentation dated November 2026 to be used with existing and potential shareholders regarding its proposed business combination with OpenPayd Holdings Limited, as described in its June 1, 2026 Form 8-K (amended July 9, 2026). The filing contains no financial results, deal terms, valuation, or quantitative metrics; the substantive content resides in Exhibit 99.1, which is not included in the provided text. The item is furnished rather than filed and carries standard forward-looking statement and no-offer disclaimers.
- · Business combination requires shareholder approval of Titan, satisfaction of Business Combination Agreement closing conditions, and Nasdaq listing standards post-closing
- · PubCo has filed a Form F-4 registration statement with the SEC including a proxy statement/prospectus
- · Exhibit 99.1 (Investor Presentation) is furnished, not filed, under Section 18 of the Exchange Act
03-11-2026
Newbury Street II Acquisition Corp (NTWOU) amended its Amended and Restated Memorandum and Articles of Association by special resolution, replacing the definition of "Completion Window" in Article 1.1. The window for completing a business combination now runs from the IPO closing date through the date twenty-seven (27) months after that closing, subject to earlier or later dates approved by the Directors or Members under the Articles.
- · The amendment was adopted as a special resolution with immediate effect.
- · The Directors may approve an earlier end date, and the Members may approve a later end date, in accordance with the Articles.
03-11-2026
SPACCircle Acquisition Corp. consummated its initial public offering on October 28, 2026, selling 10,000,000 units at $10.00 per unit for gross proceeds of $100,000,000, and simultaneously completed a private placement of 266,590 units to its sponsor for $2,665,900. Of the combined proceeds, $100,500,000 ($10.05 per unit) was placed in a U.S.-based trust account, and the underwriters' over-allotment option was not exercised, resulting in the forfeiture of 750,000 Class B ordinary shares by the sponsor.
- · Over-allotment option not exercised; underwriters informed the Company on November 2, 2026
- · Sponsor forfeited 750,000 Class B ordinary shares, which were cancelled by the Company
- · Trust account funded at $10.05 per unit, above the $10.00 IPO price
- · Company is an emerging growth company and has not elected to use the extended transition period for new or revised accounting standards
- · Audited balance sheet as of October 28, 2026 reflecting IPO and Private Placement proceeds filed as Exhibit 99.1
03-11-2026
SPACCircle Sponsor LLC, together with its managing member SPACCatalyst LLC and managing members Soumen Das (a director of the Issuer) and MiteshKumar Patel, filed a Schedule 13D reporting beneficial ownership of 5,266,590 Ordinary Shares of SPACCircle Acquisition Corp., equal to 34.50% of the 15,266,590 Ordinary Shares outstanding as of November 3, 2026. The position consists of 266,590 Class A Ordinary Shares acquired as Placement Units at $10.00 each on October 28, 2026, and 5,000,000 Class B (founder) shares, reflecting the forfeiture of 750,000 founder shares on November 2, 2026 after the underwriters let the over-allotment option lapse. The reporting persons state the shares were acquired for investment purposes and have agreed to vote in favor of any proposed business combination and not to redeem shares in connection with it.
- · The Sponsor's Class B shares are convertible one-for-one into Class A shares at the business combination or earlier at holder's option
- · Placement Unit warrants become exercisable 30 days after consummation of the initial business combination
- · Certain shares are subject to lock-up restrictions described in Item 6 of the filing
- · Reporting persons disclaim beneficial ownership beyond their pecuniary interest for Das and Patel
- · Sole voting and dispositive power is reported for the Sponsor; shared power is reported as zero
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 13 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →November 03, 2026
US Pre-Market SEC Filings Roundup — November 03, 2026
US Pre-Market SEC Filings Roundup
November 02, 2026
US Pre-Market SEC Filings Roundup — November 02, 2026
US Pre-Market SEC Filings Roundup
November 02, 2026
Nasdaq 100 Stocks SEC Filings — November 02, 2026
Nasdaq 100 Stocks SEC Filings
November 02, 2026
S&P 500 Consumer Staples Sector SEC Filings — November 02, 2026
S&P 500 Consumer Staples Sector SEC Filings